Skip to main content
Clinical Trials/NL-OMON44326
NL-OMON44326
Completed
Not Applicable

Genes involved in the induction and resolution of eczema using the Atopy Patch Test as an in vivo model for atopic dermatitis - APT and markers for eczema

niversitair Medisch Centrum Utrecht0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atopic dermatitis (AD)
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • age 18\-70 years
  • positive APT

Exclusion Criteria

  • Active AE on the patients back
  • \- Not sensitized to aeroallergens, such as house dust mite (demonstrated by a positive immuno CAP test for these allergens)
  • \- Treatment with systemic immunosuppressive medication (including corticosteroids and cyclosporin) within the 4 weeks prior to having the biopsies performed. In addition, weekly use of equal or more than 50 grams of topical corticosteroids class IV or weekly use of equal or more than 100 grams of topical corticosteroids class III.
  • \- Exposure of biopsy location to high levels of UV radiation (e.g. UV\-therapy, use of tanning booths, sunbathing) in the 2 weeks prior to taking biopsies
  • \- Use of antihistamines in the week or days before and during the APT ( see patientinformation 'Bijlage 4: medicatielijst')

Outcomes

Primary Outcomes

Not specified

Similar Trials